POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

Bibliographic Details
Main Authors: A. HAVASI, H.J. Lachmann, N. Leung, S. Kumar, A.J. Waxman, A.D. Wechalekar, K.S. Gries, X. Qin, H. Pei, N. Tran, B.M. Weiss, V. Sanchorawala
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921009785
id doaj-ff4d0b47037b440b81ae856a8c745800
record_format Article
spelling doaj-ff4d0b47037b440b81ae856a8c7458002021-04-18T06:32:10ZengElsevierKidney International Reports2468-02492021-04-0164S347POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDYA. HAVASI0H.J. Lachmann1N. Leung2S. Kumar3A.J. Waxman4A.D. Wechalekar5K.S. Gries6X. Qin7H. Pei8N. Tran9B.M. Weiss10V. Sanchorawala11Boston University, School of Medicine, Boston, United StatesUniversity College London, n/a, London, United KingdomMayo Clinic Rochester, n/a, Rochester, United StatesMayo Clinic Rochester, n/a, Rochester, United StatesHospital of the University of Pennsylvania, n/a, Philadelphia, United StatesUniversity College London, n/a, London, United KingdomJanssen Research & Development- LLC, n/a, Raritan, United StatesJanssen Research & Development- LLC, n/a, Spring House, United StatesJanssen Research & Development- LLC, n/a, Titusville, United StatesJanssen Research & Development- LLC, n/a, Los Angeles, United StatesJanssen Research & Development- LLC, n/a, Spring House, United StatesBoston University, School of Medicine, Boston, United Stateshttp://www.sciencedirect.com/science/article/pii/S2468024921009785
collection DOAJ
language English
format Article
sources DOAJ
author A. HAVASI
H.J. Lachmann
N. Leung
S. Kumar
A.J. Waxman
A.D. Wechalekar
K.S. Gries
X. Qin
H. Pei
N. Tran
B.M. Weiss
V. Sanchorawala
spellingShingle A. HAVASI
H.J. Lachmann
N. Leung
S. Kumar
A.J. Waxman
A.D. Wechalekar
K.S. Gries
X. Qin
H. Pei
N. Tran
B.M. Weiss
V. Sanchorawala
POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
Kidney International Reports
author_facet A. HAVASI
H.J. Lachmann
N. Leung
S. Kumar
A.J. Waxman
A.D. Wechalekar
K.S. Gries
X. Qin
H. Pei
N. Tran
B.M. Weiss
V. Sanchorawala
author_sort A. HAVASI
title POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
title_short POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
title_full POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
title_fullStr POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
title_full_unstemmed POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
title_sort pos-799 effect of daratumumab/bortezomib/cyclophosphamide/dexamethasone on renal function and hrqol in patients with newly-diagnosed al amyloidosis with renal involvement: results from the phase 3 andromeda study
publisher Elsevier
series Kidney International Reports
issn 2468-0249
publishDate 2021-04-01
url http://www.sciencedirect.com/science/article/pii/S2468024921009785
work_keys_str_mv AT ahavasi pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT hjlachmann pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT nleung pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT skumar pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT ajwaxman pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT adwechalekar pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT ksgries pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT xqin pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT hpei pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT ntran pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT bmweiss pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
AT vsanchorawala pos799effectofdaratumumabbortezomibcyclophosphamidedexamethasoneonrenalfunctionandhrqolinpatientswithnewlydiagnosedalamyloidosiswithrenalinvolvementresultsfromthephase3andromedastudy
_version_ 1721523187955531776